Bank of New York Mellon
TNGX icon

Bank of New York Mellon’s Tango Therapeutics TNGX Stock Holding History

Bank of New York Mellon’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2M Buy
390,920
+72,462
+23% +$1.79M ﹤0.01% 1920
2026
Q1 		$6.66M Sell
318,458
-25,382
-7% -$353K ﹤0.01% 2156
2025
Q4 		$3.05M Buy
343,840
+151,492
+79% +$1.31M ﹤0.01% 2609
2025
Q3 		$1.62M Buy
192,348
+4,351
+2% +$29.4K ﹤0.01% 2931
2025
Q2 		$963K Buy
187,997
+74,764
+66% +$185K ﹤0.01% 3145
2025
Q1 		$155K Buy
113,233
+10,213
+10% +$25.1K ﹤0.01% 3940
2024
Q4 		$318K Sell
103,020
-8,715
-8% -$40.5K ﹤0.01% 3752
2024
Q3 		$860K Sell
111,735
-29,888
-21% -$285K ﹤0.01% 3222
2024
Q2 		$1.22M Buy
141,623
+15,373
+12% +$119K ﹤0.01% 3081
2024
Q1 		$1M Sell
126,250
-14,718
-10% -$158K ﹤0.01% 3150
2023
Q4 		$1.4M Sell
140,968
-13,705
-9% -$119K ﹤0.01% 3007
2023
Q3 		$1.74M Buy
154,673
+13,418
+9% +$81.8K ﹤0.01% 2890
2023
Q2 		$469K Sell
141,255
-149
-0.1% -$536 ﹤0.01% 3633
2023
Q1 		$559K Sell
141,404
-4,947
-3% -$28.7K ﹤0.01% 3440
2022
Q4 		$1.06M Sell
146,351
-1,845
-1% -$13K ﹤0.01% 3167
2022
Q3 		$537K Buy
148,196
+13,812
+10% +$59K ﹤0.01% 3531
2022
Q2 		$608K Buy
134,384
+109,163
+433% +$661K ﹤0.01% 3466
2022
Q1 		$191K Hold
25,221
– – ﹤0.01% 4260
2021
Q4 		$276K Hold
25,221
– – ﹤0.01% 4135
2021
Q3 		$326K Buy
+25,221
New +$302K ﹤0.01% 4009

Other funds holding TNGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of New York Mellon's TNGX Position: Q2 2026 in Review

Bank of New York Mellon increased its Tango Therapeutics (TNGX) stake by 23% in Q2 2026, buying an estimated $1.79M and bringing the position to 390,920 shares worth $12.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1920.

Bank of New York Mellon first reported a position in TNGX in Q3 2021 and has held it in 20 quarters since. 95 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Bank of New York Mellon held 390,920 shares of Tango Therapeutics worth $12.2M as of Q2 2026.
  • Bank of New York Mellon bought 72,462 Tango Therapeutics shares in Q2 2026, an estimated $1.79M.
  • Tango Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1920 holding.
  • Bank of New York Mellon first reported a position in Tango Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • 95 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.